Menu

Beta Bionics, Inc. BBNX

Full chart Compare
Set alert

Price alert · BBNX

All alert types
15.70 USD +0.21 (+1.36%)

At closeNov 6, 2026, 4:00 PM EST

15.70 0.00 0.00%

After hours · Nov 6, 4:00 PM ET

14.38 Day range 15.81
8.86 52-week range 31.99
YTD
-48.47%
1 year
-37.30%

Revenue & Expenses

Revenue → Gross Profit: $55.54MGross Profit → Expenses: $55.54MRevenue → Cost of Revenue: $44.71MExpenses → Selling, General & Admin: $92.43MExpenses → Research & Development: $34.79MExpenses → Other Expenses: $1.52MNet Loss → Expenses: $73.20MGross Profit$55.54MNet Loss$73.20MCost of Revenue$44.71MExpenses$128.74MSelling, General & Admin$92.43MResearch & Development$34.79MOther Expenses$1.52MRevenue$100.25M

Latest period ending Dec 31, 2025 · select a line to chart its full history

BBNX annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022
100.25M65.12M11.99M179.00K
55.54M35.89M6.31M179.00K
-71.68M-45.25M-35.85M-65.84M
-73.20M-54.76M-44.10M-64.75M
-1.81-8.60-8.31-6.58
BBNX annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022
31.68M30.43M26.67M27.77M
328.74M149.65M110.04M35.53M
41.13M73.63M51.43M22.53M
7.30M7.25M4.22M4.13M
287.61M-245.36M-203.10M-170.03M
BBNX annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022
-50.92M-48.27M-32.45M-60.21M
-162.81M-3.48M-69.69M-769.00K
214.87M55.62M101.03M56.78M
-5.30M-3.35M-398.00K-769.00K
1.14M3.87M-1.11M-4.20M